Blogs: The Reinvented Pharmacist

Compounding vs. Manufacturing

Published Online: Thursday, February 21, 2013
My colleague Jim Jorgenson has recently weighed in on the compounding vs. manufacturing issue with a thoughtful perspective in the American Journal of Pharmacy Benefits. He provides a good history on the issue. While acknowledging that compounding is a part of pharmacy practice and is still needed today, he offers his perspective on why pharmacy compounding has grown.

He focuses on the reality that some pharmacy operations will continue to need to outsource product compounding and suggests that the American Society of Health-System Pharmacists (ASHP) Foundation’s Outsourcing Sterile Products Preparation: Contractor Assessment Tool and the ASHP Guidelines on Outsourcing Sterile Compounding Services provide useful recommendations on how to outsource pharmacy compounding safely.

I recommend a review of this commentary if you are in the pharmacy compounding business, either because you outsource that activity or because you yourself do pharmacy compounding.
Fred Eckel, RPh, MS, Editor-in-Chief of Pharmacy Times
Blog Info
This blog focuses on what our Editor-in-Chief sees as the future of pharmacy.
Author Bio
Fred Eckel, RPh, MS, is the Editor-in-Chief of Pharmacy Times, a position he has held since 2002. Mr. Eckel is a professor at the Eshelman School of Pharmacy, University of North Carolina at Chapel Hill. He serves as executive director of the North Carolina Association of Pharmacists.

In this blog, Eckel will provide commentary on relevant issues impacting pharmacists and pharmacy professionals, including the merging of pharmacy benefit managers, the implications of health care reform, the conversion of major drugs from prescription to over-the-counter, trends in pharmacy careers, and opioid abuse. He will also discuss legislative issues that impact pharmacists, and comment on the evolving role of the pharmacist.
Blog Archive
Latest Issues